Our partner ITF HELLAS, the Greek subsidiary of Italfarmaco Group, over the years has improved the gynaecological clinical practice for the management of PCOS in Greece with the introduction in July 2012 of Inofolic (with the Brand INOFERT) which proved to be a great success among the Greek gynaecological medical class. After nine years it is about to bring innovation with the launch of the new lNOFOLIC line: HP & Luteal: new tools developed by Lolipharma’s R&D to manage the inositol resistant patients and to support endometrial receptivity.